Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title, insurance, and closing services for home buyers and others, as well as originates and sells securitization commercial mortgage loans. In addition, the company is involved in the fund investment activity. It primarily serves first-time, move-up, active adult, and luxury homebuyers. The company was founded in 1954 and is based in Miami, Florida.

Lennar Corporation Class A

In a report released today, Dominic OKane from J.P. Morgan reiterated a Hold rating on Glencore, with a price target of p560.00. OKane covers the B...

J.P. Morgan Keeps Their Hold Rating on Glencore (GLEN)

The latest announcement is out from Ellenbarrie Industrial Gases Limited ( ($IN:ELLEN) ). Ellenbarrie Industrial Gases Limited has released an inve...

Ellenbarrie Industrial Gases Releases Q4 and FY26 Investor Presentation

The latest update is out from Ellenbarrie Industrial Gases Limited ( ($IN:ELLEN) ). Ellenbarrie Industrial Gases Limited has published its audited ...

Ellenbarrie Industrial Gases Publishes FY 2026 Audited Results in Newspapers

Lenz Therapeutics, Inc. (($LENZ)) has held its Q1 earnings call. Read on for the main highlights of the call. Lenz Therapeutics’ latest earnings ca...

Lenz Therapeutics Earnings Call Balances Promise and Risk

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tectonic Therapeutic (TECX) and LENZ Therapeutics (L...

Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and LENZ Therapeutics (LENZ)

In a report released on May 8, from Berenberg Bank maintained a Hold rating on Lenzing, with a price target of €24.00. The company’s shares closed ...

Berenberg Bank Reaffirms Their Hold Rating on Lenzing (0NCV)

Barclays analyst Ian Rossouw CFA maintained a Buy rating on Glencore today and set a price target of £6.25. Rossouw CFA covers the Basic Materials ...

New Buy Rating for Glencore (GLEN), the Basic Materials Giant

Glencore ( ($GB:GLEN) ) has issued an announcement. Glencore has published the notice and proxy materials for its 2026 annual general meeting, sche...

Market Cap	$30.78B	P/E Ratio	15.21
52W High	$144.24	52W Low	$81.18
Div Yield	200.0%	Payout Ratio	29.1%
EPS Growth 3Y	-20.3%	52W Position	12.9%
Overall Score	60	Value Score	100
Quality Score	63	Technical Score	18

EPS Current Est	$5.87	EPS Next Est	$7.63
EPS Growth Est	+30.0%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LEN	$89.29	+0.48%	2.47M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LEN	$89.29	+0.5%	2.47M
3
4
5
6

LEN

LEN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Lennar Corporation Class A Data in Excel

Get Lennar Corporation Class A Data in Excel